# Nautilus Biotechnolgy, Inc. (NAUT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NAUT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -14.70M | $ -13.61M | N/A | $ 144.42M |
| 2025 | $ 0 | $ -60.41M | $ -53.22M | $ 30.02M | $ 156.97M |
| 2024 | $ 0 | $ -74.40M | $ -64.40M | $ 30.48M | $ 208.73M |
| 2023 | $ 0 | $ -68.85M | $ -58.55M | $ 34.63M | $ 265.35M |
| 2022 | $ 0 | $ -64.71M | $ -53.77M | $ 30.33M | $ 314.92M |
| 2021 | $ 0 | $ -51.91M | $ -56.97M | $ 30.03M | $ 363.58M |
| 2020 | $ 0 | $ -19.90M | $ -19.00M | $ 4.78M | $ -29.72M |
| 2019 | $ 0 | $ 3.33M | $ -418.2K | $ 275.00M | $ 18.05M |
| 2018 | $ 0 | $ 827.54M | $ -314.72M | $ 5.00M | $ 5.00M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 0.23 |
| Current Ratio | 11.85 |

## Other views

- [Metrics](https://sponda.capital/en/NAUT.md)
- [Charts](https://sponda.capital/en/NAUT/charts.md)
- [Compare](https://sponda.capital/en/NAUT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.